Cunningham Ann Michelle
Insider CIK 1764572 · VTGN CHIEF COMMERCIAL OFFICER, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2025-09-09 | 2025-09-11 | 17,600 | — | $0 | 17,600 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2024-09-06 | 2024-09-10 | 14,100 | — | $0 | 14,100 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2024-03-04 | 2024-03-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2021-05-01 | 2021-05-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-12-30 | 2021-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-04-23 | 2020-04-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-10-21 | 2019-10-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-05-23 | 2019-05-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-01-10 | 2019-01-14 | 25,000 | — | $0 | 25,000 | SEC↗ |